

Man and machine
The Briefing
Having amassed more than 2 million patient years of data, Novartis sits on what is probably one of the most valued treasures in the pharmaceutical industry. But to make sense of it, artificial intelligence, or AI, is only part of the solution. Asking the right questions is crucial to getting the most out of the data. Likewise, when it comes to leprosy, data is only part of the solution to eliminating this disease. But used in the right fashion, it can make a difference in the fight to make leprosy a thing of the past once and for all.
Published on 22/03/2021
Thanks for reading Live.Magazine
Stay connected by subscribing to our newsletter
SubscribeBy submitting your email, you consent to Novartis AG collecting and processing your email data for Novartis internal use, in accordance with our privacy policy, and by protected technical means.




